250 - Where HIV and COVID-19 Collide

Saturday, October 22, 2022

1:45 PM – 3:00 PM US ET

Location: 207 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Eric Daar, M.D.

Chief, Division of HIV Medicine
Medicine
Lundquist Institute at Harbor-UCLA Medical Center
Torrance, California, United States

Disclosure(s): Gilead: Advisor/Consultant (), Grant/Research Support (); Merck: Advisor/Consultant (); ViiV: Advisor/Consultant (), Grant/Research Support ()
Caitlin Moran, MD

Assistant Professor of Medicine, Infectious Diseases
Emory University
Decatur, GA, United States

Disclosure(s): No financial relationships to disclose

Faculty(s)

Magdalena Sobieszczyk, MD, MPH

Chief, Division of Infectious Diseases
Physicians and Surgeons, NewYork-Presbyterian Columbia University Irving Medical Center, New York, NY, USA
New York, NY, United States

Disclosure(s): Bill and Melinda Gates Foundation: Grant/Research Support (Ongoing); Gilead Science: Grant/Research Support (Ongoing); Janssen Global Services, LLC: Grant/Research Support (Ongoing); Merck Inc: Grant/Research Support (Ongoing); National Institute of Allergy and Infectious Diseases (NIAID): Grant/Research Support (Ongoing); NIH: Grant/Research Support (Ongoing); Sanofi Pasteur Inc.: Grant/Research Support (Ongoing)

Slides
Adam Lauring, MD, PhD

Professor
Internal Medicine, Microbiology and Immunology
University of Michigan
Ann Arbor, MI, United States

Disclosure(s): Roche Inc: Advisor/Consultant (Ongoing); Sanofi Pasteur Inc.: Advisor/Consultant (Ongoing)

Slides
Amanda Castel, MD, MPH

Professor
The George Washington University Milken School of Public Health
Washington, DC, United States

Disclosure(s): No relevant disclosure to display

Slides

Disclosure(s):

Eric S. Daar, M.D.: Gilead: Advisor/Consultant (), Grant/Research Support (); Merck: Advisor/Consultant (); ViiV: Advisor/Consultant (), Grant/Research Support ()

Caitlin Moran, MD: No financial relationships to disclose

Magdalena E. Sobieszczyk, MD, MPH: Bill and Melinda Gates Foundation: Grant/Research Support (Ongoing); Gilead Science: Grant/Research Support (Ongoing); Janssen Global Services, LLC: Grant/Research Support (Ongoing); Merck Inc: Grant/Research Support (Ongoing); National Institute of Allergy and Infectious Diseases (NIAID): Grant/Research Support (Ongoing); NIH: Grant/Research Support (Ongoing); Sanofi Pasteur Inc.: Grant/Research Support (Ongoing)

Adam S. Lauring, MD, PhD: Roche Inc: Advisor/Consultant (Ongoing); Sanofi Pasteur Inc.: Advisor/Consultant (Ongoing)

Amanda Derryck Castel, MD, MPH: No relevant disclosure to display

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

assess COVID-19 vaccines and treatments for people with HIV;
evaluate the virology of COVID-19 in populations who are immunocompromised;
discuss the impact of the COVID-19 pandemic on the HIV care continuum

Presentations:

1:45 PM – 2:10 PM US ET

Vaccines and Monoclonal Antibodies
Speaker: Magdalena E. Sobieszczyk, MD, MPH – Physicians and Surgeons, NewYork-Presbyterian Columbia University Irving Medical Center, New York, NY, USA
2:10 PM – 2:35 PM US ET

Virology of COVID-19 in Immunosuppressed Populations
Speaker: Adam S. Lauring, MD, PhD – University of Michigan
2:35 PM – 3:00 PM US ET

COVID-19 and the HIV Care Continuum
Speaker: Amanda Derryck Castel, MD, MPH – The George Washington University Milken School of Public Health